Welcure Drugs & Pharmaceuticals has informed that the next meetings of the Audit Committee and the Board of Directors of the Company will be held on January 01, 2017 to take on record the un-audited financial results for the quarter ended on December 31, 2016.
The above information is a part of company’s filings submitted to BSE.
